Single Molecule Protein Folding Studies

Lead Research Organisation: University of Cambridge
Department Name: Chemistry

Abstract

Proteins are one of the most diverse classes of biological macromolecule in both the structures that they form and the functions that they perform. Proteins are involved in every biological process, and their misfunction is associated with disease states including cancer in a very large number of cases. Having completed the human genome and many other mapping projects, there are now vast databases of information on the primary (amino acid) sequence of proteins in many organisms. In some cases, knowledge of the primary sequence itself may be sufficient to predict how a protein may fold and function. However, in many other cases, the primary sequence alone tells us little about the structure or activity of the protein. Being able to predict the structure of a protein from its amino acid sequence is a major goal in the 21st century and is part of what is termed the 'protein folding problem'. Knowledge of the structure that a protein adopts is crucial in the design of small molecules which will bind to it and affect its activity (the basis of many therapeutic drugs). Another important and related aspect of the protein folding problem is the determination of the pathways by which proteins fold. The energy landscapes for folding which determine the pathway(s) by which a protein will fold are complex. There are some fundamental questions about these energy landscapes which cannot be addressed by studying protein folding in bulk solution, looking at the average behaviour of many molecules. In order to address such questions as the heterogeneity of folding pathways and to get information on the individual behaviour of unfolded protein molecules in the denatured ensemble (the unfolded state of the protein and the starting point for any folding study) single-molecule experiments are required. Single-molecule spectroscopy has advanced significantly over the last ten years, however, there remain very few studies of single molecule protein folding. These type of experiments are increasingly important as the number of computational studies which simulate the folding of a single protein chain has increased dramatically in the last five years. Experimental single molecule data are desperately needed to compare with computational results to facilitate the benchmarking and improvement of the computational methods. The main difficulty in measuring single molecule protein folding is the requirement to study a reaction far from equilibrium. Technical developments and new methodologies have been recently developed in the Klenerman group which will allow us to make the single molecule measurements needed. The two proteins which will be studied are the small, stable protein ubiquitin, and the large beta-barrel protein GFP. These are two proteins whose folding pathways have been studied in detail from bulk solution results in the Jackson laboratory and which show quite different folding behaviours. They make ideal systems with which to test the single molecule experiments proposed and to develop the techniques further which can then be generally applied.

Technical Summary

Despite the many technical advances in single-molecule measurements over the past ten years, there are still remarkably few single-molecule studies of protein folding. This is largely due to the inherent difficulties in making single-molecule measurements on systems far from equilibrium. The Klenerman group has recently developed novel single-molecule techniques to do just this based on new nanopipette technology. We have used this technique to successfully monitor the unfolding of a dye-labelled citrine variant of GFP at a single-molecule level. We now propose to extend these measurements on citrine to study i) the unfolding reaction under different conditions, ii) the refolding of GFP and iii) to characterise the ensemble of denatured states. Results will be compared to those obtained from bulk solution. In order to do this, a number of variants of GFP will be synthesised in which the protein will be doubly labelled with suitable dyes to allow a series of fluorescence resonance energy transfer. The fluorophores will be located on different structural elements in GFP allowing us to obtain specific information on the formation of different regions of the complex beta-barrel structure and identify any intermediates formed. In addition, the small monomeric protein, ubiquitin, will also be studied using similar single-molecule and labelling techniques. In collaboration with the Searle group, measurements on mutants of ubiquitin which are known to fold via stable intermediate states will also be undertaken. This set of experiments will not only establish the methodology for single-molecule folding measurements, which can then be applied to other proteins, but it will also provide new information on the pathways taken from the unfolded to folded state for these two proteins and hence the energy landscape. These results can also be compared with the single-molecule simulations of unfolding/folding.
 
Description We have made progress towards understanding key biological self assembly processes including the how proteins with complex structures fold. Folding is essential for the function of many cellular proteins and misfolding is associated with a large number of disease states. One important family of proteins that was studied was Fluorescent Proteins such as GFP. These are a very important class of proteins used in a wide variety of biological and medical research projects and assays. Not only did we learn considerably more about how the fold but also about how their fluorescence properties can be very sensitive to solution conditions such as the presence of chloride ions. This is important as many fluorescent proteins are used as sensors.
In addition, considerable technical developments were made during the award. In particular, a much improved method for studying the fluorescence of single molecules was developed whereby microfluidic devices were employed so that systems could be studied under flow. This not only lead to improvements in the general methods but also lead onto further developments such as rapid-dilution technology. Such a technology will be very important in greatly increasing the types of biological systems that we will be able to study using these highly-sensitive single molecule techniques.
Exploitation Route The technical developments that were accomplished during the award are already being used by other academic research groups. They also continue to be used and further developed in our groups as well as others to obtain considerably better data and also greatly expand on the type of systems that can be studied using the single molecule techniques.
A greater understanding of how proteins with complex structures fold, which we have obtained from the research undertaken, is contributing to our understanding of this challenging self assembly process. Ultimately this will facilitate the design of proteins with complex structures with stable and kinetically accessible structures and specific functions.
An additional project which we undertook during the award but which was not an objective of the original proposal, has been important in developing a new method for studying a key biological process - that of ubiquitination and degradation. These biological processes are involved in a wide variety of disease states, and some of the components of the system are known pharmaceutical targets. The knowledge and methods gained from our research is having an impact on this important field and ultimately will help in understanding the biological system with a view to the development of therapeutic strategies and drugs.
Sectors Pharmaceuticals and Medical Biotechnology

 
Description Research conducted as part of the award has lead to five publications in high impact journals. Many of these publications are being well cited (between 6-23 times) and various research communities are using the either the knowledge generated, or the methodologies developed, as part of the award.
First Year Of Impact 2009
Sector Pharmaceuticals and Medical Biotechnology
 
Title Expression vectors for mutant forms of ubqiuitin and fluorescent proteins 
Description Experssion vectors were constructed for mutants of the proteins ubiquitin, yellow fluorescent protein, Venus and blue fluorescent protein. The constructs made are suitable for dye labelling experiments for single-molecule and ensemble fluorescence measuerments including FRET 
Type Of Material Model of mechanisms or symptoms - in vitro 
Provided To Others? No  
Impact Despite the fact that we have not passed on the expression vectors to other groups, other groups are using the method we developed as part of one of the research projects that was undertaken, see our Nature paper 2012. In this paper we describe the development of a general method which uses labelled ubiquitin molecules and an in vitro assembly reaction to generate poly-ubiquitin chains with FRET pairs capable of providing insight into conformational dynamics. We then go on and show how single-molecule methods can be used to obtain information on conformational dynamics that it is not possible to get from bulk measurements. A number of groups world wide are now adopting the same methodology. 
 
Title Integration of microfluidic devices with single-molecule fluorescence confocal microscopes 
Description In the course of the grant, microfluidic devices were integrated into single-molecule fluorescence confocal microscopes. This enabled single-molecule measurements to be made under flow. This greatly improved the signal-to-noise and lead to significant improvements overall with the technique. This was reported in the publication in ACS Nano in 2013. Ultimately this lead on to some current developments where the microfluidic devices are being used to enable rapid dilution of samples from high concentrations to the picomolar concentrations required for single-molecule work. This greatly expands the number of complexes that can be studied using single-molecule approaches if they have sufficiently low dissociation rates. 
Type Of Material Technology assay or reagent 
Provided To Others? No  
Impact There has been a general move within the single-molecule field towards use of microfluidic devices. Our work provided more important data that established the advantages of studying molecules under flow. 
 
Description established a new collaboration with the Komander group at the LMB in Cambridge 
Organisation Medical Research Council (MRC)
Department MRC Laboratory of Molecular Biology (LMB)
Country United Kingdom 
Sector Academic/University 
PI Contribution We used our singly labelled constructs of ubiquitin to generate specifically labelled di-ubiquitin chains to study poly-ubiquitin chain dynamics and recognition and in doing so have established a new collaboration with a group at the LMB in Cambridge. The Alexa-dye labelled variants of ubiquitin generated as part of the BBSRC project were used to create specifically linked, dye-labelled chains of ubiquitin. We have used these and our single-molecule techniques to gain important information on the dynamics of poly-ubiquitin chains and their recognition by a number of ubiquitin-binding proteins including deubiquitinating enzymes. This work is now under review at Nature.
Start Year 2009
 
Title Alexa dye labelled constructs of ubiquitin and fluorescent proteins 
Description Both single and dual-labelled proteins have been produced with Alexa 488 and Alexa 647 for the single-molecule measurements. 
Type Of Technology New Material/Compound 
Impact No actual Impacts realised to date 
 
Title Microfluidic devices to measure fast kinetics using single-molecule fluorescence methods 
Description During the project we used the nanopipette as outlined in the proposal but have also developed microfluidic and microdroplet devices to use with the single-molecule instrumentation which has enabled us to acquire data faster and to obtain better signal-to-noise. These techniques are currently being optimised and will be used in future projects. 
Type Of Technology New/Improved Technique/Technology 
Impact No actual Impacts realised to date